| Title : Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's disease - Cutler_1992_J.Geriatr.Psychiatry.Neurol_5_192 |
| Author(s) : Cutler NR , Sramek JJ , Murphy MF , Nash RJ |
| Ref : J Geriatr Psychiatry Neurol , 5 :192 , 1992 |
| Abstract : Cutler_1992_J.Geriatr.Psychiatry.Neurol_5_192 |
| ESTHER : Cutler_1992_J.Geriatr.Psychiatry.Neurol_5_192 |
| PubMedSearch : Cutler_1992_J.Geriatr.Psychiatry.Neurol_5_192 |
| PubMedID: 1418362 |
Cutler NR, Sramek JJ, Murphy MF, Nash RJ (1992)
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's disease
J Geriatr Psychiatry Neurol
5 :192
Cutler NR, Sramek JJ, Murphy MF, Nash RJ (1992)
J Geriatr Psychiatry Neurol
5 :192